bf/NASDAQ:ABOS_icon.jpeg

NASDAQ:ABOS

Acumen Pharmaceuticals, Inc.

  • Stock

USD

Last Close

1.90

06/11 21:09

Market Cap

137.58M

Beta: -

Volume Today

129.63K

Avg: 100.61K

PE Ratio

−3.53

PFCF: −3.92

OverviewFinancialsAPI

    Description

    Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorpora...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -8-6-4-22020-03-302021-03-312022-11-142024-05-142025-03-25

    Revenue (Estimate*)

    500K1M1.50M2020-03-302021-03-312022-11-142024-05-142025-03-25

    *Estimate based on analyst consensus